Answers are grounded in this paper and cite their sources.
An original two-step sequence allowing the full oxidation of an α-arylated isochromane is described. This method has been safely implemented to manufacture diketone 2 at the kg scale, a key intermediate in the manufacturing route of a phase II post stroke Servier clinical candidate S44819 . This second-generation synthesis showcased better safety, replicability, and sustainability compared to the first-generation synthesis using an excess amount of Jones reagent. Further functionalization of 2 by cyclodehydration and condensation with hydrazine is also demonstrated, allowing the manufacture of clinical candidate S44819 at the kg scale.
No takes yet. Share an insight, caveat, or question.
Giffard et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: